Drug Development
Editorial
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Degron Enters Collaboration & License Agreement with Takeda
Will discover and develop novel molecular glue degraders for multiple targets in oncology, neuroscience, and inflammation.05.23.24
-
Breaking News | Drug Development | Industry News
MilliporeSigma Agrees to Acquire Mirus Bio for $600M
Mirus Bio develops & commercializes transfection reagents, which play a critical role in the production of viral vector-based gene therapies.05.23.24
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development
AGC Biologics, BioConnection Partner to Provide End-to-End Biopharma Development & Manufacturing
New partnership offers a seamless, full-service clinical-stage development and manufacturing solution.05.22.24
-
Bio News | Breaking News | Drug Development | Industry News
Biogen Agrees to Acquire HI-Bio for $1.15B
HI-Bio’s lead asset, felzartamab, is a monoclonal antibody with potential to improve clinical outcomes in a broad range of immune-mediated diseases.05.22.24
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Medigene & BioNTech Extend T Cell Receptor Immunotherapy Collaboration
Will enable ongoing and future work required to potentially generate novel TCRs directed against multiple newly nominated antigen targets.05.21.24
-
Breaking News | Collaborations & Alliances | Drug Development
Astellas, Yaskawa Discuss Potential Creation of Innovative Cell Therapy Ecosystem
Aim to seamlessly link early-stage research to commercialization to manufacture high-quality products and shorten the R&D period of cell therapy.05.21.24
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
TFF Pharmaceuticals, Cleveland Clinic to Advance Multiple Influenza Vaccines
Aim to develop a first-in-class, stable, universal, easy-to-transport and easy-to-stockpile vaccine.05.20.24
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Catalent to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies for cancer.05.17.24
-
Bio News | Breaking News | Drug Development | Drug Discovery | Promotions & Moves
Regulus Therapeutics Names New Chief Medical Officer
Dr. Rekha Garg is a physician executive with over 20 years of experience in leadership roles in the biopharma industry.05.16.24
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development
FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)
Aim to transform outcomes for patients with multiple types of cancer.05.14.24
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Centogene and Evotec Discover New Potential Treatment for Gaucher Disease
Companies amend existing drug discovery partnership for Evotec to lead continued development.05.14.24
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Takeda, AC Immune Ink Exclusive Agreement for Alzheimer’s Immunotherapy
Worldwide option and license agreement includes AC Immune’s active immunotherapies targeting toxic forms of amyloid beta, including ACI-24.060.05.14.24
-
Biologics, Proteins, Vaccines | Drug Development
The Transformative Potential of Gene Therapy
Gene therapy is having its moment. Can the clinical research ecosystem seize it?James Riddle, Senior Vice President, Global Review Operations, Advarra 05.13.24
-
Biologics, Proteins, Vaccines | Drug Development
CDMOs: The Cornerstone of Biopharmaceutical Innovation
CDMOs provide specialized support, knowledge, and infrastructure to accelerate drug development and get new drugs to the market sooner.Leonardo Magneschi, Head of Molecular Biology, Ingenza 05.13.24
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Promotions & Moves
ERS Genomics Appoints John E. Milad CEO
John brings more than 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences.05.13.24
-
Breaking News | Collaborations & Alliances | Drug Development
Fulcrum Enters Collaboration & License Agreement with Sanofi
Following positive data from the Phase 3 trial, Fulcrum and Sanofi plan to submit marketing applications for losmapimod.05.13.24
-
Breaking News | Collaborations & Alliances | Drug Development
AbbVie, Gilgamesh Pharma Partner on Next-Gen Psychiatric Therapies
Will leverage AbbVie's psychiatry expertise and Gilgamesh's research platform to develop neuroplastogens to treat psychiatric disorders.05.13.24
-
Breaking News | Collaborations & Alliances | Drug Development
Novo Nordisk, Metaphore Biotechnologies Enter Obesity Therapeutics Research Pact
Aim to develop up to two next-generation therapeutics for obesity management.05.09.24
-
Breaking News | Clinical Trials | Drug Development
Aardvark Therapeutics Announces $85M Series C Financing
Will use the proceeds from the financing to advance the regulatory approval of its lead asset, ARD-101.05.09.24
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
ExcellGene, Cytovance Partner to Advance Biologics Development and Manufacture
Will combine ExcellGene’s transposon technologies with Cytovance’s cGMP manufacturing expertise.05.08.24
